Pages that link to "Q42469816"
Jump to navigation
Jump to search
The following pages link to The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations (Q42469816):
Displaying 50 items.
- Riluzole for Parkinson's plus disorders (Q24194067) (← links)
- Second consensus statement on the diagnosis of multiple system atrophy (Q24650965) (← links)
- Review: Multiple system atrophy: emerging targets for interventional therapies (Q26770919) (← links)
- Neuroinflammation in Multiple System Atrophy: Response to and Cause of α-Synuclein Aggregation (Q26771536) (← links)
- Glia and alpha-synuclein in neurodegeneration: A complex interaction (Q26851153) (← links)
- Exploring myelin dysfunction in multiple system atrophy (Q26852634) (← links)
- Animal modeling an oligodendrogliopathy--multiple system atrophy (Q28074659) (← links)
- A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism (Q28075227) (← links)
- Brain MR Contribution to the Differential Diagnosis of Parkinsonian Syndromes: An Update (Q28076062) (← links)
- Multiple system atrophy: clinicopathological characteristics in Japanese patients. (Q30234494) (← links)
- Impairment of brainstem implicit learning paradigms differentiates multiple system atrophy (MSA) from idiopathic Parkinson syndrome (Q30544858) (← links)
- Parkin disease: a clinicopathologic entity? (Q30594306) (← links)
- Free-water imaging in Parkinson's disease and atypical parkinsonism (Q31034031) (← links)
- Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients (Q33326684) (← links)
- Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy (Q33668478) (← links)
- Towards translational therapies for multiple system atrophy (Q33797532) (← links)
- Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates (Q33805560) (← links)
- α-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy (Q33864597) (← links)
- Camptocormia in Parkinson's disease (Q34181112) (← links)
- The neuropathology, pathophysiology and genetics of multiple system atrophy (Q34231585) (← links)
- α-Synucleinopathy phenotypes (Q34386816) (← links)
- When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients (Q34483397) (← links)
- Alpha-synuclein mRNA expression in oligodendrocytes in MSA. (Q34548507) (← links)
- Binding of the radioligand SIL23 to α-synuclein fibrils in Parkinson disease brain tissue establishes feasibility and screening approaches for developing a Parkinson disease imaging agent (Q34584062) (← links)
- Clinical outcomes of progressive supranuclear palsy and multiple system atrophy (Q34767058) (← links)
- Automated, high accuracy classification of Parkinsonian disorders: a pattern recognition approach (Q34838098) (← links)
- Distinct Neurochemical Profiles of Spinocerebellar Ataxias 1, 2, 6, and Cerebellar Multiple System Atrophy (Q34951012) (← links)
- Microstructural changes across different clinical milestones of disease in amyotrophic lateral sclerosis (Q35202637) (← links)
- Filamentous aggregations of phosphorylated α-synuclein in Schwann cells (Schwann cell cytoplasmic inclusions) in multiple system atrophy (Q35627057) (← links)
- Individual time course of pre- and postsynaptic PET imaging may improve differential diagnosis of Parkinson's disease and multiple system atrophy: a case report (Q35792439) (← links)
- Overexpression of α-synuclein in oligodendrocytes does not increase susceptibility to focal striatal excitotoxicity (Q35857994) (← links)
- Network correlates of disease severity in multiple system atrophy (Q35883193) (← links)
- Serum Levels of Coenzyme Q10 in Patients with Multiple System Atrophy (Q35905033) (← links)
- Coenzyme Q10 Levels Are Decreased in the Cerebellum of Multiple-System Atrophy Patients. (Q35928302) (← links)
- Chronic exposure to cerebrospinal fluid of multiple system atrophy in neuroblastoma and glioblastoma cells induces cytotoxicity via ER stress and autophagy activation (Q35955278) (← links)
- Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation (Q35996880) (← links)
- The alpha-synuclein gene in multiple system atrophy (Q36142276) (← links)
- Striatofrontal Deafferentiation in MSA-P: Evaluation with [18F]FDG Brain PET. (Q36248897) (← links)
- Models of multiple system atrophy (Q36513407) (← links)
- Bladder dysfunction in a transgenic mouse model of multiple system atrophy. (Q36549533) (← links)
- Cellular pathology in multiple system atrophy (Q36589164) (← links)
- Expanding the spectrum of neuronal pathology in multiple system atrophy (Q36825501) (← links)
- Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP-C. (Q36885378) (← links)
- α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy? (Q36925651) (← links)
- Multiple system atrophy: alpha-synuclein and neuronal degeneration (Q37003479) (← links)
- Clinicopathological aspects of motor parkinsonism (Q37082003) (← links)
- Distinct functional and macrostructural brain changes in Parkinson's disease and multiple system atrophy (Q37108101) (← links)
- In vivo evaluation of gray and white matter volume loss in the parkinsonian variant of multiple system atrophy using SPM8 plus DARTEL for VBM (Q37184765) (← links)
- Stages of pTDP-43 pathology in amyotrophic lateral sclerosis (Q37202139) (← links)
- Diffusion tensor imaging in the characterization of multiple system atrophy. (Q37226500) (← links)